Virginia Biotechnology Association

06/03/2026

🎉 Congratulations to our THRiVE survey respondent winners, who have each received complimentary registration to a future Virginia Bio event!

Thank you to everyone who attended THRiVE and took the time to share feedback through our post-event survey. Your insights help us continue to improve and create meaningful experiences for Virginia's life sciences community.

We can't wait to see you at an upcoming Virginia Bio event!

Still missing the energy and excitement of THRiVE? Take a look back at some of our favorite moments, captured by Nick Davis Photography. 📸

View the full photo gallery: https://bit.ly/4399mzB

06/02/2026

06/01/2026

“Chairman Griffith, along with other members of Congress, rightly questioned whether hospital systems are using 340B savings to lower patient costs or using the program to generate revenue. His expressed concerns reflect a growing recognition in Congress that the 340B program is raising costs for all Americans while not adequately serving the vulnerable patients for which it was intended.”

In Cardinal News, learn more about how the program has run off course and is driving up costs for families across the Commonwealth from pediatric rheumatologist Dr. Harry Gewanter. Congressman Morgan Griffith is right to demand answers and hold hospitals accountable for how billions in 340B savings are being used. Read more:

What was meant to be a patient-focused program is now a hospital markup program where large, tax-exempt hospital systems buy discounted drugs, mark them up by as much as 1,000% or more and bill pat…

05/28/2026

🎉 A warm welcome to some of the newest additions to the Virginia Bio community!

We’re excited to spotlight PILMA(Pharmaceutical Industry Labor Management Association), Glen Research, Nexus CMC Advisors, and S1P Therapeutics Inc. as new members of our growing network.

From advancing scientific discovery to providing strategic expertise and industry support, these organizations bring valuable perspectives that help drive innovation across the life sciences ecosystem. We’re thrilled to have them involved and look forward to the collaborations ahead.

👏 Be sure to connect with them and help us give them a warm welcome!

05/21/2026

We’re thrilled to announce the recipients of Virginia Bio’s 2026 Outstanding Contributions to Bioscience Award, Scott Meza and Nikki Hastings! 🎉🧬

Both Scott and Nikki have played an incredible role in advancing Virginia’s life sciences ecosystem through leadership, advocacy, collaboration, and a deep commitment to innovation across the Commonwealth. Their work continues to strengthen and grow Virginia’s bioscience community in meaningful ways.

It was an honor to announce and present these awards during , surrounded by so many leaders, innovators, and champions of Virginia life sciences.

Read more about this year’s award recipients here: https://bit.ly/4wHpoxX

05/19/2026

Virginia Bio applauds Governor of Virginia for vetoing SB271 and HB483! We appreciate the Governor’s thoughtful leadership and commitment to ensuring healthcare affordability policies are carefully evaluated for their impact on patients, providers, employers, and innovation across the Commonwealth.

Virginia Bio looks forward to continuing to work with the Spanberger Administration and state leaders on patient-centered solutions that improve affordability while supporting scientific advancement and economic growth in Virginia.

05/01/2026

“By supporting PBM transparency while remaining engaged on insurance reform and innovation-friendly policy, [Senator Warner] is helping chart a path forward that balances affordability with access and discovery.”

In The Virginian-Pilot, Virginia Bio CEO John Newby applauds Senator Mark Warner for co-sponsoring Senate Bill 3345, the PBM Price Transparency and Accountability Act. Pharmacy benefit managers play a central role in determining patient access to medicines, yet their practices often lack transparency or accountability. S. 3345 brings meaningful accountability to those practices — and Warner's support signals that Virginia's leaders understand how much is at stake for patients and the life sciences community alike. Read more:

PBM reform championed by Sen. Warner is a necessary step to lower health care costs for patients, VA Bio’s John Newby writes in a guest column

04/17/2026

Virginia Bio applauds Abigail Spanberger for taking action to stop rushed government price-setting policies from taking effect in Virginia. By requiring the federal Maximum Fair Price provisions in SB271/HB483 to be re-enacted in 2027, this amendment blocks flawed federal price caps that threaten patient access, weaken medical innovation, and put the Commonwealth’s life sciences leadership at risk.

This is a major victory for patients, for innovation, and for Virginia’s future as a national biotech leader.

04/16/2026

3 - 2 - 1 - NETWORK! 🚀

Registered THRiVE 2026 attendees get early access to a private networking link to start connecting before the event.

📅 April 30
📍 Capital One – West Creek Commons

🔗 https://bit.ly/4s1RgLb

04/03/2026

Are you attending THRiVE 2026?

Have you booked your hotel yet? Our room block deadline is quickly approaching. Be sure to reserve your room before April 7 to receive the discounted rate.

Don’t miss your chance to stay with fellow attendees and be right in the middle of the THRiVE energy.

📍 Hilton Richmond Hotel & Spa/Short Pump

Book your room: http://bit.ly/4kbtB7o